The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety

Neuropharmacology

Volumn 39, Issue 10, 2000, Pages 1848-1857

  Griebel, Guy ^a   Rodgers, R John ^b   Perrault, Ghislaine ^a   Sanger, David J ^a  

^a SANOFI   (France)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

5 HT(1A) receptor antagonists; Anxiety; Conflict tests; Diazepam; Elevated plus maze; Rats

Indexed keywords

AUTORECEPTOR; DIAZEPAM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SL 88.0338; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; COMPARATIVE STUDY; CONFLICT; CONTROLLED STUDY; ELECTRIC SHOCK; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PUNISHMENT; RAT; SHOCK; SPECIES DIFFERENCE;

AMINOPYRIDINES; ANIMALS; ANXIETY; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; ISOQUINOLINES; MALE; MAZE LEARNING; MOTOR ACTIVITY; PINDOLOL; PIPERAZINES; PIPERIDINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; SUCCINIMIDES;

EID: 0034089626     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00074-5     Document Type: Article

References (71)

1. Apter J.T., Allen L.A. Buspirone: future directions. Journal of Clinical Psychopharmacology. 19:1999;86-93.
2. 1B receptors. Neuropharmacology. 35:1996;213-222.
3. 1A-agonist EMD 68843. Society of Neuroscience Abstracts. 22:1996;613.
4. 1A antagonist, on social and agonistic behavior in male albino mice. Pharmacology, Biochemistry and Behaviour. 46:1993;67-72.
5. Belzung C., Le Pape G. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiology & Behaviour. 56:1994;623-628.
6. Beuzen A., Belzung C. Link between emotional memory and anxiety states: a study by principal component analysis. Physiology & Behaviour. 58:1995;111-118.
7. Bickerdike M.J., Wright I.K., Marsden C.A. Social isolation attenuates rat forebrain 5-HT release induced by KCl stimulation and exposure to a novel environment. Behavioural Pharmacology. 4:1993;231-236.
8. 1A receptor antagonists (+)WAY100135 and WAY100635. Neuropharmacology. 34:1995;805-811.
9. Bill D.J., Knight M., Forster E.A., Fletcher A. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. British Journal of Pharmacology. 103:1991;1857-1864.
10. Blanchard D.C., Cholvanich P., Blanchard R.J., Clow D.W., Hammer R.P. Jr., Rowlett J.K., Bardo M.T. Serotonin, but not dopamine, metabolites are increased in selected brain regions of subordinate male rats in a colony environment. Brain Research. 568:1991;61-66.
11. 1A autoreceptors: S15535 and 8-OH-DPAT block ultrasonic vocalizations and aggression in a WAY 100,635-reversible fashion. Society of Neuroscience Abstracts. 22:1996;236.
12. 1A receptor antagonist, in the murine elevated plus-maze. Psychopharmacology. 129:1997;365-371.
13. 1A. Pharmacology, Biochemistry and Behaviour. 58:1997;583-591.
14. 1A. 2. WAY 100635, SDZ 216-525 and NAN-190. Pharmacology, Biochemistry and Behaviour. 58:1997;593-603.
15. 1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice. Psychopharmacology. 139:1998;185-194.
16. 1A receptor antagonist, WAY 100635. Neuroscience and Biobehaviour Review. 23:1998;247-257.
17. 1A receptor inverse agonist, SL88.0338-08. Society of Neuroscience Abstracts. 24:1998;1364.
18. Cole J.C., Rodgers R.J. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro16-6028) in the murine elevated plus-maze. Behavioural Pharmacology. 4:1993;573-580.
19. 1A antagonist, WAY 100635. Psychopharmacology. 132:1997;35-43.
20. Crespi F., Wright I.K., Mobius C. Isolation rearing of rats alters release of 5-hydroxytryptamine and dopamine in the frontal cortex: an in vivo electrochemical study. Experimental Brain Research. 88:1992;495-501.
21. File S.E. Behavioural detection of anxiolytic action. Elliott J.M., Heal D.J., Marsden C.A. Experimental Approaches to Anxiety and Depression. 1992;25-44 Wiley, Chichester, UK.
22. File S.E., Zangrossi H. Jr., Andrews N. Novel environment and cat odor change GABA and 5-HT release and uptake in the rat. Pharmacology, Biochemistry and Behaviour. 45:1993;931-934.
23. 1A receptor modulation of anxiety in two ethological animal tests. Journal of Neuroscience. 16:1996;4810-4815.
24. 1A receptor antagonist. Behavioural Brain Research. 73:1995;337-353.
25. Goa K.L., Ward A. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs. 32:1986;114-129.
26. Griebel G. Serotonergic drugs in animal models of anxiety: an update. Serotonin ID Research Alert. 2:1997;251-257.
27. Griebel G., Rodgers R.J., Perrault G., Sanger D.J. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmacology, Biochemistry and Behaviour. 57:1997;817-827.
28. Griebel G., Perrault G., Sanger D.J. Characterization of the behavioral profile of the non peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents - comparison with diazepam and buspirone. Psychopharmacology. 138:1998;55-66.
29. 1A receptor antagonists. Psychopharmacology. 144:1999;121-130.
30. Griebel G., Sanger D.J., Perrault G. The use of the rat elevated plus-maze to discriminate non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Psychopharmacology. 124:1996;245-254.
31. 1A receptor mutant mice. Proceedings of the National Academy of Science of the USA. 95:1998;15049-15054.
32. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology, Biochemistry and Behaviour. 54:1996;21-30.
33. 1A receptor antagonists and their interaction on the fear-potentiated startle response. Psychopharmacology. 139:1998;383-390.
34. Kawahara H., Yoshida M., Yokoo H., Nishi M., Tanaka M. Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neuroscience Letters. 162:1993;81-84.
35. 2B receptor mediated. Neuropharmacology. 37:1998;1603-1610.
36. 1A receptor ligands in a modified Geller-Seifter conflict model in the rat. European Journal of Pharmacology. 325:1997;121-128.
37. 1A receptor antagonist: p-MPPI. Life Science. 55:1994;1459-1462.
38. 125I] p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies. Journal of Pharmacology and Experimental Therapeutics. 272:1995;429-437.
39. 1A receptor antagonist. Pharmacology, Biochemistry and Behaviour. 38:1991;555-559.
40. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
41. 1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice. Pain. 58:1994;45-61.
42. 1A receptors. 2. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. Journal of Pharmacology and Experimental Therapeutics. 282:1997;148-161.
43. 1A receptors. Medical and Chemical Research. 4:1994;161-169.
44. Olivier B., Molewijk H.E., Vanderheyden J.A.M., vanOorschot R., Ronken E., Mos J., Miczek K.A. Ultrasonic vocalizations in rat pups, effects of serotonergic ligands. Neuroscience and Biobehaviour Review. 23:1998;215-227.
45. Overshiner C.D., Benvenga M.J., Leander J.D. Comparison of punished responding and conditioned suppression in pigeons and rats. Society of Neuroscience Abstracts. 21:1995;1131.
46. 1A receptor. Proceedings of the National Academy of Science of the USA. 95:1998;10734-10739.
47. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Research. 346:1985;205-230.
48. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods. 14:1985;149-167.
49. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Science of the USA. 95:1998;14476-14481.
50. 1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology. 125:1996;89-91.
51. Rodgers R.J. Animal models of "anxiety": where next? Behavioural Pharmacology. 8:1997;477-496.
52. 1A receptor agonist, flesinoxan. Pharmacology, Biochemistry and Behaviour. 48:1994;959-963.
53. 3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice. Psychopharmacology. 117:1995;306-312.
54. 1A receptor antagonist, LY297996. Behavioural Pharmacology. 9(Suppl. 1):1998;S78.
55. 1A receptor partial agonist, increases rates of punished responding in rats: comparison with chlordiazepoxide, ipsapirone and WAY 100635. Society of Neuroscience Abstracts. 22:1996;607.
56. 1A receptors play an important role in modulation of behavior of rats in a two-compartment black and white box. Behavioural Pharmacology. 7:1996;788-797.
57. Sanger D.J., Joly D., Zivkovic B. Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide. Journal of Pharmacology and Experimental Therapeutics. 232:1985;831-837.
58. Schreiber R., Melon C., Devry J. The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology. 135:1998;383-391.
59. Setem J., Pinheiro A.P., Motta V.A., Moratto S., Cruz A.P.M. Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze. Pharmacology, Biochemistry and Behaviour. 62:1999;515-521.
60. Shekhar A., Katner J.S., Rusche W.P., Sajdyk T.J., Simon J.R. Fear-potentiated startle elevates catecholamine levels in the dorsomedial hypothalamus of rats. Pharmacology, Biochemistry and Behaviour. 48:1994;525-529.
61. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterization of the elevated zero-maze as an animal model of anxiety. Psychopharmacology. 116:1994;56-64.
62. Soderpalm A., Blomqvist O., Soderpalm B. The yohimbine-induced anticonflict effect in the rat.1. Involvement of noradrenergic, serotonergic and benzodiazepinergic mechanisms. Journal of Neural Transmission - Genetics Section. 100:1995;175-189.
63. Soderpalm A., Ehrenstrom F., Soderpalm B. The yohimbine-induced anticonflict effect in the rat, Part II. Neurochemical findings. Journal of Neural Transmission - Genetics Section. 100:1995;191-206.
64. 1A receptor agonists, partial agonists and a silent antagonist on the performance of the conditioned emotional response test in the rat. Psychopharmacology. 128:1996;293-303.
65. Thielen R.J., Fangon N.B., Frazer A. 4-(2′-Methoxyphenyl)-1-[2′-[N-(2″-pyridinyl)-p-iodobenzamido] ethyl]piperazine and 4-(2′-methoxyphenyl)-1-[2′-[N-(2″-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors. Journal of Pharmacology and Experimental Therapeutics. 277:1996;661-670.
66. Vogel J.R., Beer B., Clody D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia. 21:1971;1-7.
67. 1 receptors in the vertebrate brain. Regional distribution examined by autoradiography. Naunyn-Schmiedeberg's Archives of Pharmacology. 340:1989;486-494.
68. Winter J.C., Rabin R.A. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. Journal of Pharmacology and Experimental Therapeutics. 263:1992;682-689.
69. 1A receptors and relationship to anxiolytic effect. European Journal of Pharmacology. 323:1997;59-68.
70. Yoshioka M., Matsumoto M., Togashi H., Saito H. Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex. Pharmacology, Biochemistry and Behaviour. 51:1995;515-519.
71. 1A ligand. Journal of Medicinal Chemistry. 37:1994;1406-1407.